Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fulgent Genetics Inc (NQ: FLGT )

34.00 -2.21 (-6.10%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 235,526
Open 35.39
Bid (Size) 33.69 (2)
Ask (Size) 34.48 (1)
Prev. Close 36.21
Today's Range 33.89 - 35.80
52wk Range 28.53 - 73.47
Shares Outstanding 29,438,052
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
From Scott+Scott Attorneys at Law LLP
Via Business Wire

Performance

YTD
+10.89%
+10.89%
1 Month
+12.25%
+12.25%
3 Month
-4.28%
-4.28%
6 Month
-35.51%
-35.51%
1 Year
-48.66%
-48.66%

More News

Read More
Fulgent Expands Board of Directors with Addition of Reggie Groves
From Fulgent Genetics, Inc.
Via Business Wire
Where Fulgent Genetics Stands With Analysts
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Fulgent Genetics's Return on Invested Capital Insights
Via Benzinga
1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings
Via The Motley Fool
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Which Is the Better Buy: Vertex or Invitae?
Via The Motley Fool
My Top 7 Strong Conviction Buys for 2023
Via InvestorPlace
4 Analysts Have This to Say About Fulgent Genetics
Via Benzinga
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Fulgent Genetics, Inc.’s Directors and Officers for Breach of Fiduciary Duties – FLGT
From Scott+Scott Attorneys at Law LLP
Via Business Wire
FLGT FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action - FLGT
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)
From The Law Offices of Frank R. Cruz
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Via Benzinga
Fulgent Genetics to Participate in Piper Sandler’s 34th Annual Healthcare Conference
From Fulgent Genetics, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fulgent, Yatsen, Barclays, and Warner Bros. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
FLGT DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors With Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - FLGT
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
NASDAQ:FLGT Investor Alert: Deadline on November 21, 2022 in Lawsuit Against Fulgent Genetics, Inc.
Via SBWire
Deadline Alert: Fulgent Genetics, Inc. (FLGT) - Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Class Action Deadlines and Encourages Shareholders to Contact the Firm and Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Palantir, Fulgent, Yatsen, and Barclays and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Fulgent Genetics, Inc.
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
ROSEN, A TOP RANKED FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important November 21 Deadline in Securities Class Action - FLGT
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Fulgent Genetics Acquires Fulgent Pharma, Creating a New Paradigm in Precision Medicine for The Company
From Fulgent Genetics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.